As of November 2024, Sinphar Pharmaceutical has a market cap of $172.01M. This makes Sinphar Pharmaceutical the world's 18244th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $169.91M | -4.57% |
2023 | $178.04M | 2.41% |
2022 | $173.84M | 14.71% |
2021 | $151.55M | -6.62% |
2020 | $162.30M | 59.54% |
2019 | $101.74M | 0.52% |
2018 | $101.21M | -10.85% |
2017 | $113.53M | -10.35% |
2016 | $126.64M | -12.03% |
2015 | $143.96M | -31.86% |
2014 | $211.28M | -8.21% |
2013 | $230.18M | 52.16% |
2012 | $151.27M | 35.85% |
2011 | $111.35M | -31.63% |
2010 | $162.87M | 14.68% |
2009 | $142.02M | 51.96% |
2008 | $93.46M | -21.69% |
2007 | $119.35M | 51.45% |
2006 | $78.80M | -11.54% |
2005 | $89.08M | 38.12% |
2004 | $64.50M | 13.87% |
2003 | $56.64M | 7.46% |
2002 | $52.71M | - |